CNMD * Stock Overview A medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
CONMED Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for CONMED Historical stock prices Current Share Price US$1,454.00 52 Week High US$1,454.00 52 Week Low US$1,179.00 Beta 1.46 1 Month Change 0% 3 Month Change 4.87% 1 Year Change -22.82% 3 Year Change n/a 5 Year Change n/a Change since IPO -12.19%
Recent News & Updates
CONMED Corporation Declares Quarterly Cash Dividend, Payable on January 3, 2025 Dec 10
CONMED Corporation Revises Earnings Guidance for the Full Year 2024 Nov 02 CONMED Corporation Announces Chief Executive Officer Changes
CONMED Corporation to Report Q3, 2024 Results on Oct 30, 2024 Oct 04
Upcoming dividend of US$0.20 per share Sep 09
Insufficient new directors Aug 20 See more updates
CONMED Corporation Declares Quarterly Cash Dividend, Payable on January 3, 2025 Dec 10
CONMED Corporation Revises Earnings Guidance for the Full Year 2024 Nov 02 CONMED Corporation Announces Chief Executive Officer Changes
CONMED Corporation to Report Q3, 2024 Results on Oct 30, 2024 Oct 04
Upcoming dividend of US$0.20 per share Sep 09
Insufficient new directors Aug 20
CONMED Corporation Announces Termination of Stanley W. (Bill) Peters as President, Advanced Surgical & Advanced Endoscopic Technologies, Effective August 31, 2024 Aug 15
Second quarter 2024 earnings released: EPS: US$0.97 (vs US$0.45 in 2Q 2023) Aug 01
CONMED Corporation Revises Earnings Guidance for the Full Year 2024 Aug 01
Insufficient new directors Jul 18
CONMED Corporation to Report Q2, 2024 Results on Jul 31, 2024 Jul 09
Upcoming dividend of US$0.20 per share Jun 09
First quarter dividend of US$0.20 announced May 26
CONMED Corporation Declares Quarterly Cash Dividend, Payable on July 5, 2024 May 23
Chief Operating Officer recently bought Mex$3.5m worth of stock May 03
Insufficient new directors May 02 CONMED Corporation Revises Earnings Guidance for the Full Year 2024
Insufficient new directors Apr 10
CONMED Corporation, Annual General Meeting, May 22, 2024 Apr 10
CONMED Corporation, Annual General Meeting, May 22, 2024 Apr 09
CONMED Corporation to Report Q1, 2024 Results on Apr 24, 2024 Apr 03
CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024 Feb 28
CONMED Corporation Provides Financial Guidance for the Full Year 2024 Feb 01
CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2024 Dec 06
Insufficient new directors Nov 16
CONMED Corporation Updates Third Quarter Guidance for 2023 Oct 26
Insufficient new directors Oct 11
CONMED Corporation to Report Q3, 2023 Results on Oct 25, 2023 Oct 05
Insufficient new directors Sep 19
CONMED Corporation Announces Quarterly Cash Dividend, Payable on October 5, 2023 Aug 11
Second quarter 2023 earnings released: EPS: US$0.45 (vs US$5.65 loss in 2Q 2022) Jul 28
CONMED Corporation Revises Earnings Guidance for the Full Year 2023 Jul 27
Insufficient new directors Jul 21
CONMED Corporation to Report Q2, 2023 Results on Jul 26, 2023 Jul 06
CONMED Corporation Announces Quarterly Cash Dividend, Payable on July 5, 2023 May 25
Insufficient new directors May 12
Insufficient new directors Apr 13
Full year 2022 earnings released: US$2.68 loss per share (vs US$2.15 profit in FY 2021) Feb 05
CONMED Corporation Provides Earnings Guidance for the Full Year 2023 Feb 03
Insufficient new directors Jan 31
CONMED Corporation to Report Q4, 2022 Results on Feb 02, 2023 Jan 10
CONMED Corporation Announces Management Changes Dec 08
CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2023 Dec 06
Insufficient new directors Dec 01
CONMED Corporation Provides Revenue Guidance for the Full Year 2023 Nov 16
Insufficient new directors Nov 01
Now 24% undervalued after recent price drop Oct 29
Third quarter 2022 earnings released: EPS: US$1.51 (vs US$0.51 in 3Q 2021) Oct 27
CONMED Corporation Revises Earnings Guidance for the Full Year 2022 Oct 27
Now 21% undervalued Oct 11
CONMED Corporation to Report Q3, 2022 Results on Oct 26, 2022 Oct 11
Insufficient new directors Oct 02
Chairman of the Board recently sold Mex$6.6m worth of stock Sep 18
Now 21% undervalued after recent price drop Sep 07
Upcoming dividend of US$0.20 per share Sep 07
CONMED Corporation Announces Quarterly Cash Dividend, Payable on October 5, 2022 Aug 12
CONMED Corporation (NYSE:CNMD) completed the acquisition of Biorez, Inc. Aug 11
CONMED Corporation (NYSE:CNMD) completed the acquisition of Biorez, Inc. Aug 10
CONMED Corporation (NYSE:CNMD) has entered into a definitive agreement to acquire Biorez, Inc. for $250 million. Aug 03
CONMED Corporation (NYSE:CNMD) has entered into a definitive agreement to acquire Biorez, Inc. for $250 million. Aug 02
Second quarter 2022 earnings released: US$5.65 loss per share (vs US$0.46 profit in 2Q 2021) Jul 28
CONMED Corporation Revises Earnings Guidance for the Full Year 2022 Jul 28
CONMED Corporation to Report Q2, 2022 Results on Jul 27, 2022 Jul 06
CONMED Corporation(NYSE:CNMD) dropped from Russell 2000 Dynamic Index Jun 26
Now 20% undervalued Jun 17
CONMED Corporation (NYSE:CNMD) completed the acquisition of In2Bones Global, Inc. Jun 14
Upcoming dividend of US$0.20 per share Jun 07 Shareholder Returns CNMD * MX Medical Equipment MX Market 7D 0% 0% 0% 1Y -22.8% 0% 0%
See full shareholder returns
Return vs Market: CNMD * underperformed the MX Market which returned -3.3% over the past year.
Price Volatility Is CNMD *'s price volatile compared to industry and market? CNMD * volatility CNMD * Average Weekly Movement n/a Medical Equipment Industry Average Movement 0% Market Average Movement 0% 10% most volatile stocks in MX Market 0% 10% least volatile stocks in MX Market 0%
Stable Share Price: CNMD *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine CNMD *'s volatility change over the past year.
About the Company CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.
Show more CONMED Corporation Fundamentals Summary How do CONMED's earnings and revenue compare to its market cap? CNMD * fundamental statistics Market cap Mex$49.32b Earnings (TTM ) Mex$2.71b Revenue (TTM ) Mex$26.52b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) CNMD * income statement (TTM ) Revenue US$1.29b Cost of Revenue US$569.15m Gross Profit US$718.96m Other Expenses US$587.22m Earnings US$131.74m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 4.26 Gross Margin 55.82% Net Profit Margin 10.23% Debt/Equity Ratio 100.6%
How did CNMD * perform over the long term?
See historical performance and comparison Dividends
1.0% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/11/26 11:58 End of Day Share Price 2024/08/29 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources CONMED Corporation is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Travis Steed Barclays Travis Steed BofA Global Research Kristen Stewart CL King & Associates, Inc.
Show 11 more analysts 